Only US- FDA medication approved for any eating disorder to date.
A first-line treatment option in adolescents with moderate to severe depression.
Provides a better analgesic effect than a placebo in treating persistent somatoform pain disorder.
Shows a clear antiaggressive effect in impulsive aggressive individuals with intermittent explosive disorder.
Also beneficial in :
Obsessive-compulsive disorder
Bulimia nervosa
Panic disorder
Premenstrual dysphoric disorder
Price: